Influenza vaccine, adjuvanted (Novartis)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza vaccine, adjuvanted (Novartis)
Drug Alias Name三价流感病毒表面抗原fluadVantaflu
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/11/24
Country/TerritoryCanadaPanamaUnited States +[7
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesNovartis Vaccines
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A